Eagle Pharmaceuticals
EGRX
#9847
Rank
โ‚ฌ20.46 M
Marketcap
1,58ย โ‚ฌ
Share price
0.00%
Change (1 day)
-62.38%
Change (1 year)

Earnings for Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): โ‚ฌ32.75 Million

According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ0.25 Billion. In 2022 the company made an earning of โ‚ฌ57.8 Million, an increase over its 2021 earnings that were of -โ‚ฌ2.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eagle Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) โ‚ฌ32.75 M-43.33%
2022 โ‚ฌ57.8 M-2361.45%
2021 -โ‚ฌ2.56 Million-111.53%
2020 โ‚ฌ22.16 M2.31%
2019 โ‚ฌ21.66 M-32.89%
2018 โ‚ฌ32.27 M-50.35%
2017 โ‚ฌ65 M38.63%
2016 โ‚ฌ46.89 M1966.43%
2015 โ‚ฌ2.26 M-111.46%
2014 -โ‚ฌ19.81 Million282.82%
2013 -โ‚ฌ5.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ15.30 B 48,813.32%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.85 B 12,223.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ11.96 B 38,151.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-โ‚ฌ0.25 Billion-890.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚ฌ4.04 B 12,825.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ11.12 B 35,460.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ7.36 Billion-23,597.57%๐Ÿ‡บ๐Ÿ‡ธ USA